Trial Profile
A phase I study of ZX-007, a third generation abuse-deterrent tablet formulation of hydrocodone ER, for the treatment of pain
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 27 Apr 2015
Price :
$35
*
At a glance
- Drugs Hydrocodone (Primary)
- Indications Pain
- Focus Adverse reactions; Therapeutic Use
- 27 Apr 2015 New trial record
- 24 Apr 2015 Zogenix plans to submit an NDA for this third-generation product in mid-2016.